Home

CAR-T Companies and Organizations

Included core activities: CAR-T (14)
The number in () indicates the number of employers worldwide

14 Locations

10 Employers

Allogene Therapeutics

Business Area(s): 
Description: 

Allogene Therapeutics is a biotechnology company developing allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors.

Autolus

Business Area(s): 
Description: 

Autolus is at the forefront of a revolution in cancer treatment. Chimeric Antigen Receptor (CAR) T-cell therapies have been shown to be effective in some haematological malignancies and may have ...

Beam Therapeutics

Business Area(s): 
Description: 

Beam Therapeutics is pioneering the use of CRISPR base editing to develop precision genetic medicines.

BioNTech

Business Area(s): 
Description: 

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. Its cutting-edge pipeline includes ...

CARsgen Therapeutics

Business Area(s): 
Description: 

CARsgen Therapeutics，a biopharmaceutical company based in Shanghai, with operations both in China and the U.S., is developing immunotherapeutics especially CAR-T cell therapeutics for the ...

Cell Medica

Business Area(s): 
Description: 

Cell Medica develops therapeutics based on cellular immunotherapy with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.

Dragonfly Therapeutics

Business Area(s): 

Legend Biotech

Business Area(s): 
Description: 

Legend Biotech's first product candidate, LCAR-B38M, is a B cell maturation antigen (BCMA)-directed chimeric antigen receptor T (CAR-T) cell therapy. The novel dual-epitope design of the BCMA ...

Mustang Bio

Business Area(s): 
Description: 

Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc., is a clinical‐stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products ...

Precision BioSciences

Business Area(s): 
Description: 

The backbone of the ARCUS technology is the ARC Nuclease – a fully synthetic enzyme that is very similar to a homing endonuclease but is modified to be a better starting point for the development ...

Don't see an employer? Please fill out the form